BIO-PREDISC-TIA SWISS Cohort Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

64 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-08-04

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research project aims at contributing to improve TIA diagnosis and management by using PREDISC scores and specific biomarkers thought to have elevated levels in TIA patients. A swift and accurate TIA diagnosis allows starting treatment of the patient adequately and shortly after the event. The shorter the time between the event and treatment onset, the better the outcome. This approach will be an important step forward in TIA diagnosis and management, similarly to acute coronary syndrome as discussed above.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Biomarkers for the Diagnosis of Transient Ischemic Attack

NCT02799511

Cerebrovascular Disorders Ischemic Attack, Transient

COMPLETED NA

Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk

NCT01423201

Cerebrovascular Accident

COMPLETED

Natural History of Stroke: Cause and Development

NCT00009243

Brain Disease Ischemic Attack, Transient Cerebrovascular Accident +2 more

RECRUITING

Carotid Plaque Imaging in Acute Stroke

NCT01284933

Stroke Ischemic Attack, Transient

COMPLETED

PRECISE (PERFUSION IMAGING TO IDENTIFY POSTERIOR CIRCULATION CANDIDATES FOR THROMBECTOMY)

NCT06375174

Posterior Circulation Acute Ischemic Stroke Due to Large Vessel Occlusion of the Vertebral or Basilar Artery Needing Endovascular Thrombectomy

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebrovascular Disease, Ischemic Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with suspected TIA (defined as the acute onset of focal neurological symptoms lasting \<24 h and presumed to be caused by brain ischemia at the time of referral) within 48 h of symptoms onset.

* At least 18 years old.
* Having given their Informed Consent.

Exclusion Criteria

* · Patients with ocular TIA (Amaurosis fugax).

* Patients that still have neurological deficits at the moment of inclusion.
* Contraindication to perform MRI.
* For women: pregnancy.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No